# Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer

**Authors:** Jinpeng Cen, Jiading Guo, Xianzi Zeng, Xianlu Song, Shengdong Ge, Mingkun Chen, Qianyi Li, Yuzhong Yu, Daojun Lv, Shanchao Zhao

PMC · DOI: 10.3389/fcell.2025.1646699 · Frontiers in Cell and Developmental Biology · 2025-06-25

## Full-text entities

- **Genes:** ELOVL2 (ELOVL fatty acid elongase 2) [NCBI Gene 54898] {aka SSC2}
- **Diseases:** prostate cancer (MESH:D011471)
- **Chemicals:** enzalutamide (MESH:C540278)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12238949/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12238949/full.md

---
Source: https://tomesphere.com/paper/PMC12238949